The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization

The Application of OCTA in Assessment of Anti-VEGF Therapy for Idiopathic Choroidal Neovascularization

Purpose. To assess the morphology of idiopathic choroidal neovascularization (ICNV) by optical coherence tomography angiography (OCTA) and determine the therapeutic effects of intravitreal antivascular endothelial growth factor (anti-VEGF). Method. Patients with naive ICNV were assessed by spectral...

Full description

Bibliographic Details
Main Authors:	Qin Chen, Xiaobing Yu, Zihan Sun, Hong Dai
Format:	Article
Language:	English
Published:	Hindawi Limited 2016-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2016/5608250

Similar Items

Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
by: T. Barth, et al.
Published: (2019-11-01)

Submacular predominantly hemorrhagic choroidal neovascularization: resolution of bleedings under anti-VEGF therapy
by: Dimopoulos S, et al.
Published: (2015-08-01)

Recent advance on anti-VEGF treatment of choroidal neovascularization secondary to pathological myopia
by: Xing-Zhao Xu, et al.
Published: (2018-09-01)

Macular density alterations in myopic choroidal neovascularization and the effect of anti-VEGF on it
by: Jian-Bo Mao, et al.
Published: (2021-08-01)

Biomarkers of Myopic Choroidal Neovascularization in Women, Determining the Clinical Course and Response to Anti-VEGF Therapy
by: A. V. Grigorieva, et al.
Published: (2021-06-01)

Meta-analysis of diagnostic value of OCTA for choroidal neovascularization of wet age-related macular degeneration
by: Shuang Liu, et al.
Published: (2021-07-01)

Anti-Human VEGF Repebody Effectively Suppresses Choroidal Neovascularization and Vascular Leakage.
by: Da-Eun Hwang, et al.
Published: (2016-01-01)

Anti-VEGF treatment for myopic choroid neovascularization: from molecular characterization to update on clinical application
by: Zhang Y, et al.
Published: (2015-07-01)

Choroidal Neovascularization Associated with Punctate Inner Choroidopathy: Combination of Intravitreal Anti-VEGF and Systemic Immunosuppressive Therapy
by: Bettina Hohberger, et al.
Published: (2015-11-01)

Evaluation of efficacy and recurrence for anti-vascular endothelial growth factor therapy in idiopathic choroidal neovascularization
by: Qianru Wu, et al.
Published: (2020-03-01)

Choroidal Neovascularization Regression on Fluorescein Angiography after VEGF Blockade
by: Diana V. Do, et al.
Published: (2012-11-01)

OCT and OCTA observation of polypoidal choroidal vasculopathy
by: Yan-Hong Liao, et al.
Published: (2019-10-01)

Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapy
by: Giuseppe Casalino, et al.
Published: (2019-01-01)

Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents
by: Norman A. Saffra, et al.
Published: (2015-02-01)

New Therapies of Neovascular AMD—Beyond Anti-VEGFs
by: Praveen Yerramothu
Published: (2018-07-01)

Idiopathic choroidal neovascular membrane in a young female
by: Saad Abdullah Waheeb, et al.
Published: (2009-01-01)

Idiopathic polypoidal choroidal vasculopathy in Thai patients with clinical and angiographic choroidal neovascularization
by: Bhoomibunchoo C, et al.
Published: (2017-02-01)

Removal of choroidal neovascular membrane in a case of macular hole after anti-VEGF therapy for age-related macular degeneration
by: Akira Hirata, et al.
Published: (2018-03-01)

Anti-VEGF therapy in pediatric retinal and choroidal disease
by: Yue Yin, et al.
Published: (2021-01-01)

Efficacy of anti-VEGF in the treatment of choroidal neovascular membrane secondary to pattern dystrophy simulating fundus flavimaculatus
by: Nangia, Purna, et al.
Published: (2019-06-01)

The effect of intravitreal injection of anti-VEGF drugs on the ophthalmotonus values in patients with classic and occult choroidal neovascularization
by: A.V. Kuroyedov, et al.
Published: (2018-07-01)

ANTI-ANGIOGENIC THERAPY IN PATIENTS WITH PATHOLOGIC MYOPIA AND CHOROIDAL NEOVASCULARIZATION
by: S. A. Korotkikh, et al.
Published: (2016-11-01)

Evaluation of Idiopathic Choroidal Neovascularization with Indocyanine Green Angiography in Patients Undergoing Bevacizumab Therapy
by: Ryan B. Rush, et al.
Published: (2015-01-01)

New Therapies of Neovascular AMD beyond Anti-VEGF Injections
by: Greggory M. Gahn, et al.
Published: (2018-03-01)

Application of anti-VEGF agents on the treatment of neovascular glaucoma
by: Qi-Meng Chu, et al.
Published: (2016-01-01)

Drastic effect of ranibizumab on choroidal neovascularization in idiopathic angioid streaks
by: Umit Yolcu, et al.
Published: (2015-08-01)

Optical Coherence Tomography Angiography (OCTA) information content in the diagnosis of type 1 choroidal neovascularization combined with pigment epithelium detachment
by: V. V. Neroev, et al.
Published: (2021-03-01)

Comparison of OCTA and ICGA used in polypoid choroidal vasculopathy
by: Hou-Yin Xu, et al.
Published: (2017-07-01)

Photodynamic therapy of subfoveal choroidal neovascularization
by: Georgijević Ana, et al.
Published: (2007-01-01)

Clinical efficacy of intravitreal Ranibizumab in idiopathic choroid neovascularization type Ⅰand type Ⅱ
by: Yue-Ming Sun, et al.
Published: (2015-07-01)

The Role of Optical Coherence Tomography Angiography (OCTA) in Detecting Choroidal Neovascularization in Different Stages of Best Macular Dystrophy: A Case Series
by: Yaqoob Qaseem, et al.
Published: (2021-02-01)

Optical coherence tomography characteristics of responses to intravitreal bevacizumab in idiopathic choroidal neovascularization
by: Syed Nasir Ali Shah, et al.
Published: (2016-02-01)

Occult inflammation detected by autofluorescence May Be the cause of idiopathic choroidal neovascularization
by: Luiz H. Lima, et al.
Published: (2020-12-01)

Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization
by: Chuanfeng Fan, et al.
Published: (2014-01-01)

Cytokine profiling reveals increased serum inflammatory cytokines in idiopathic choroidal neovascularization
by: Shenchao Guo, et al.
Published: (2019-04-01)

Results of Intravitreal Anti-VEGF Injection in Choroidal Neovascularization Caused by Pathologies Other Than Age-Related Macular Degeneration
by: Mehmet Ozveren
Published: (2020-08-01)

VEGF-production by CCR2-dependent macrophages contributes to laser-induced choroidal neovascularization.
by: Torsten A Krause, et al.
Published: (2014-01-01)

Effect of modified Zhu Jing prescriptions on the expression of VEGF in pathological myopia with choroidal neovascularization
by: Nan-Nan Tian, et al.
Published: (2013-08-01)

Interactions between Endostatin and Vascular Endothelial Growth Factor (VEGF) and Inhibition of Choroidal Neovascularization
by: Chunhai Fan, et al.
Published: (2007-01-01)

Anti-VEGF medicine with PRP for neovascular glaucoma
by: Yue Deng, et al.
Published: (2018-10-01)

Cannot write session to /tmp/vufind_sessions/sess_nv68aaq9bdotshpjgda281tuvc